A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia

Overview of attention for article published in Arthritis Research & Therapy, October 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

policy: 2 policy sources
twitter: 1 X user

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 53 Dimensions

Readers on

mendeley: 137 Mendeley

Summary Policy documents X Wikipedia Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Behandling och rehabilitering vid fibromyalgi

Cited by Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) on 14 Dec 2021

SBU is an independent national authority, tasked by the government with assessing health care and social service interventions from a broad perspective, covering medical, economic, ethical and social aspects.

Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain : J: Pharmacological management for chronic primary pain

Cited by National Institute for Health and Care Excellence on 06 Apr 2021

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.